OBJECTIVES: There are limited reliable data on the long-term survival of patients operated upon with double-valve surgery (DVS) in the literature. In this study, in-hospital mortality and 5-year survival were determined and the potential risk factors for increased mortality were identified and discussed.
INTRODUCTION
Studies involving concomitant mitral (MV) and aortic valve (AV) surgery are relatively few compared with those on isolated AV and MV surgery [1] [2] [3] [4] . For multivalvular disease, it is reported in the literature that the rate of overall operative risk of simultaneous aortic (AVR) and mitral valve replacement (MVR) lies between 4 and 14% and is much higher than the risk of either AVR or MVR alone, especially in older patients [1] [2] [3] [4] [5] [6] [7] . Many studies have also documented an increased mortality in double-valve surgery (DVS) patients who have a coronary artery bypass grafting (CABG) procedure performed concomitantly [1, 2, 8] .
Reliable data on the long-term survival of patients operated on with DVS are limited in the literature and are often based on reports from single-institution studies, often older than 10 years or with enrolment periods spanning decades [8] [9] [10] [11] .
The decision to repair or replace the MV when a concomitant AVR is being performed remains a matter of debate. Some authors show that mitral valve plasty (MVP) improves long-term survival compared with MVR in patients who underwent concomitant AVR [11, 12] , whereas others conclude that MVR provides greater longterm survival than MVP [9, 10, 13, 14] . Recently, a registry study based on a large cohort of patients confirmed that MVP had a significantly better in-hospital survival than MVR, but long-term survival was found to be similar for the two strategies [15] .
Finally, the outcome of different patient subgroups has not been thoroughly investigated: the treatment of elderly patients operated on with concomitant MV and AV surgery is still a matter of debate.
To cast further light on these issues, we conducted this registry study reporting outcomes from a regional large series of patients undergoing concomitant AV and MV surgery from 2002 to 2011 in Emilia-Romagna, Italy. The in-hospital mortality and long-term survival were determined and the potential risk factors for increased mortality were identified and discussed. Data for patients who underwent DVS were categorized by age, MVR or MVP, valve replacement type, sex, with or without CABG, and body mass index (BMI).
MATERIALS AND METHODS

Data source
The rationale and methodology of RERIC have been published previously [16, 17] . Briefly, RERIC Registry (Registro dell'Emilia Romagna degli Interventi Cardiochirurgici) is a prospective regional database from Emilia-Romagna (Italy) collecting pre-, intraand postoperative data from patients undergoing cardiac surgical procedures in six regional Cardiac Surgery Departments (Academic hospitals: n = 2; private hospitals: n = 4). From April 2002 to September 2013, data from n = 42 087 cardiac surgical procedures were collected. The variables were selected and extrapolated by the six Cardiac Surgery Departments from the database of the Italian Society for Cardiac Surgery (SICCH). The Regional Agency for Health and Social Care ensures data quality/completeness control. The identity of patients who died in or out of the hospital was retrieved through record linkage between RERIC and the regional mortality registry.
Study population and data collection
The study initially included 1167 patients who underwent concomitant AV and MV surgery, with or without CABG, from April 2002 to September 2011. The study population represented 7.1% of the overall 16 496 valve surgery procedures, with or without CABG, registered in RERIC in the same period. Patients who underwent redo cardiac surgery were included. Valve disease was classified as rheumatic, degenerative/functional or endocarditis. Valve pathology was classified as stenosis, regurgitation or mixed.
Patient and procedure information were collected prospectively for all patients and retrospectively reviewed and analysed. Variables included in the study are reported in Table 1 . Valve procedure was classified as replacement or repair. Valve type was classified as tissue or mechanical. The type of procedure used for MVP and postoperative valve-related complications were not collected, because the RERIC database does not provide for the inclusion of these variables. Patients not resident in the Emilia-Romagna (ER) region (306 patients) were excluded from the mid-and long-term statistical analyses because of incomplete information about their clinical follow-up after discharge from the hospital. The remaining 861 patients were followed through September 2013.
Study measures and outcomes
The outcome measures for this study were in-hospital (defined as death within the index admission) and 1-year mortality, and allcause mortality during the follow-up period. Information on the occurrence of long-term mortality was obtained by linking the RERIC to the Emilia-Romagna regional mortality registry, and the regional hospital admission database. Data for patients who underwent DVS were stratified by age, MVR or MVP, valve replacement type, sex, with or without CABG and BMI. The second objective of this study was to identify risk factors for 5-year mortality by using a statistical multivariate analysis.
Statistical analysis
All preoperative and intraoperative variables are reported as counts and percentages. Differences in patients' characteristics between procedures with or without concurrent CABG were compared with Pearson's chi-square test or Fisher's exact test as appropriate, and a P-value of <0.05 was considered to be statistically significant. All patients were followed for at least 1 year and mortality rates (in-hospital and, only for residents in ER, 1-year mortality) were also evaluated for age, gender, BMI, type of mitral procedures (replacement or repair) and type of concomitant valve. The significance of their difference was estimated by Pearson's chi-square test at a significance level of 5%.
To compare the long-term survival in subgroups, the KaplanMeier estimates were used and differences between curves were assessed by the log-rank test. Independent predictors of 5-year mortality risk were estimated using a stepwise multivariable Cox proportional hazards model including individual covariates as all pre-and intraoperative variables available and satisfying the proportional hazard assumption, assessed using the Schoenfeld residuals test.
All statistical analysis was performed using SAS 9.1.
RESULTS
The study population consisted of 1167 patients: 50.6% were <70 years old, 39.6% 70-79 years old and 9.9% ≥80 years old. The aetiology was rheumatic in 478 patients (40.9%), degenerative/functional in 630 (54%) and endocarditis in 59 (5.1%). Mitral valve lesion was due to stenosis in 362 patients (31%), regurgitation in 630 (54%), and mixed in 175 (15%). Aortic valve lesion was due to stenosis in 595 patients (51%), regurgitation in 245 (21%), and mixed in 327 patients (28%). The majority of patients (56.3%) were female. One hundred and eighty-two patients (15.6%) had a history of congestive heart failure, and 27.4% of the patients had NYHA functional class III or IV. Left ventricular ejection fraction was found to be moderately depressed (30-50%) in 338 patients (29%) and severely depressed (<30%) in 55 patients (4.7%). Other important systemic comorbidities were as follows: 61.9% had hypertension, 21.9% coronary artery disease, 13.6% diabetes with and without sequelae, 11% extra-cardiac vasculopathy, 5.3% cerebrovascular disease and 4.8% a creatinine value >2.0 mg/dl. One hundred and nine patients (9.3%) had experienced a previous valve procedure. Aortic tissue valves were implanted in 650 patients (55.7%). Most patients who had DVS underwent MVR instead of MVP (822 vs 345; 70.4 vs 29.6%). Three hundred and fifty-seven patients (30.6%) received a tissue MV and 465 (39.8%) received a mechanical MV. Concomitant CABG was performed in 200 patients (12.5%) and tricuspid valve surgery in 189 (16.2%). Most patients underwent elective surgery (95.3%), 3.9% were urgent and 0.8% were emergent. Patient characteristics are reported in Table 1 .
In-hospital and 1-year mortality figures are presented in Table 2 . The overall in-hospital mortality rate was 6.9% and the 1-year mortality rate was 12.8%. The stratification of the study population by age group showed that the in-hospital mortality rate was 5.1% in patients <70 years, 7.1% for patients between 70 and 79 years, and 14.8% in those who were ≥80 years. Moreover, the 1-year mortality rate was 8.0% in patients <70 years, 14.7% for patients between 70 and 79 years, and 27.3% in those who were ≥80 years. Both in-hospital and 1-year mortality were statistically significant between age groups (P <0.001). There was no significant difference in in-hospital and 1-year mortality between male and female gender.
BMI was categorized into four groups: the in-hospital and 1-year mortality were higher for those patients with a BMI of ≤19 (underweight), although it was statistically significant only for the in-hospital period. Concomitant CABG worsened outcomes in DVS patients, both as in-hospital mortality (12.5 vs 5.7%, P <0.05) and 1-year mortality (20.3 vs 11.1%, P <0.05). MVR showed worse in-hospital mortality than MVP (7.9 vs 4.4%; P <0.01), although this difference was lost at the 1-year follow-up. Finally, there was a significant difference in in-hospital mortality among subgroups of patients stratified by surgical strategies adopted, although it was not confirmed at the 1-year follow-up.
We further examined in-hospital and 1-year mortality related to surgical strategies in subgroups of patients stratified by age (<70 and >70 years, respectively) ( Table 3 ). The cohort was separated into five groups: aortic tissue/mitral tissue (348 patients), aortic mechanical/mitral mechanical (443 patients), aortic mechanical or tissue/mitral plasty (345 patients), aortic tissue/mitral mechanical (22 patients), aortic mechanical/mitral tissue (9 patients). In our analysis, we considered only the first three groups, because in the two smaller groups, the small size of the patient population did not permit any significant statistical conclusions. In the subgroup of patients aged <70 years, those who received tissue valves in aortic and mitral position experienced in-hospital mortality of 8.25% and 1 year mortality of 10.1%, respectively. In patients <70 years who had aortic and mitral mechanical valves, the in-hospital and 1-year mortality rates were 4.8 and 7.6%, and in patients with AVs and MVP, 2.4 and 8.1%, respectively.
In the subgroup of patients ≥70 years, the results were different. Patients with both mechanical valves had worse results, with an in-hospital mortality rate of 15.7% and 1-year mortality rate of 24.6%. In patients with aortic and mitral biological valves, in-hospital and 1-year mortality rates were 8 and 15.4%, respectively. Patients who had both an aortic prosthesis and MVP showed an in-hospital mortality rate of 5.5% and 1-year mortality rate of 14.4%. However, statistical significance in mortality rates was found only between patients aged ≤70 and ≥70 years treated with both mechanical valves.
The mean follow-up was 67.16 ± 31.8 months. In Figs 1-3 , the cumulative rate of death is shown in Kaplan-Meier curves. The number of patients at risk by year is shown under each figure. Figure 1A shows the mortality rate of the overall patient population: it reports a 1-year survival rate of 87.2% and 5-year survival rate of 75.1%. Figure 1B shows the significant differences in survival (P <0.01) stratified by age: analysis confirmed that age >80 years is a significant risk factor for mortality in the follow-up. Figure 1C illustrates that there was no significant difference between male and female gender in the 5-year mortality rate. Figure 1D shows the cumulative mortality rate stratified by BMI. A significant difference with regard to lower survival rate was noted in smaller patients (P <0.01). Figure 2A illustrates that the addition of CABG to the DVS procedure significantly affected follow-up survival (P <0.01). Figure 2B shows data for patients who had MVP compared with MVR (regardless of the type of AV prosthesis). Patients with MVP had a comparable long-term survival with those who had MVR (P = 0.07). Figure 3A shows that no survival differences were found in the group of patients <70 years stratified by surgical procedure type (P = NS). Figure 3B shows survival in patients ≥70 years of age. Elderly patients with both tissue valves had the best long-term survival of all groups of patients receiving different surgical strategies, although with no significant difference (P = NS). As shown by the multivariable Cox proportional hazards model, advanced age, preoperative history of congestive heart failure, associated coronary artery disease, advanced NYHA functional class, diabetes mellitus, preoperative central neurological dysfunction, active infective endocarditis, emergency status at time of surgery and previous valve procedures remained independent predictors of 5-year mortality (Table 4) .
DISCUSSION
The frequency of double-valve surgery remains low (3-14%) compared with isolated valve surgery for aortic and mitral pathologies [1] [2] [3] [4] . Similarly, our study population represented 7.1% of the overall 16 496 valve surgery procedures, with or without CABG, registered in RERIC in the same period.
The main findings of this study are that both in-hospital and 1-year mortality rates were significantly different between age groups. In-hospital mortality was significantly higher for patients with a smaller BMI, for those who had concomitant CABG and those who received MVR instead of MVP. No differences were detected between male and female gender.
In the subgroup of patients who had implantation of both mechanical valves, in-hospital and 1-year mortality was significantly higher in patients older than 70 years.
For patients who were alive at discharge, there were significant differences in the 5-year follow-up survival based on age, BMI and concomitant CABG. Sex and the choice between MVR and MVP did not affect 5-year survival. No survival differences were found in the group of patients <70 or ≥70 years when stratified by surgical procedure type at the 5-year follow-up.
Finally, the multivariable Cox proportional hazards model showed that patient-related factors appear to be the major Our in-hospital mortality rate (6.9%) was lower than rates published by several authors [1, 2, 8, 14, 15] , but were higher than those reported by Gillinov et al. [11] and Kim et al. [12] . Older age clearly affects both in-hospital and long-term survival in patients undergoing DVS. Recent reports suggest an even higher perioperative risk for octogenarians undergoing simultaneous AVR and MVR [18, 19] , whereas another study demonstrated that double-valve replacement for selected patients aged 80 years and older can be performed with an acceptable outcome [20] . We confirmed that both in-hospital and 1-year mortality rates were statistically significant between age groups, and that age >80 years remains a significant risk factor for mortality at the 5-year follow-up.
In-hospital and median survival rates were similar for male and female gender, in line with previous reports of DVS showing that sex was not a risk factor for in-hospital mortality [1, 2] . However, Leavitt et al. [15] reported that outcomes were better in male compared with female patients, both in terms of in-hospital survival as of longterm survival.
In our study, BMI also appears to play a role in both in-hospital and long-term survival of patients undergoing DVS. In-hospital and 5-year survival rates were similarly affected, with patients with The results of the present study do not support the theory that MVP is preferable to MVR in patients undergoing DVS. MVR showed significantly worse in-hospital mortality rates than MVP (7.9 vs 4.4%; P <0.01), but this difference disappeared at the 1-year follow-up. Moreover, patients with MVP reported a survival comparable with those who had MVR at 5 years. Our results are similar to those obtained by Leavitt et al. [15] , and different from those of Gillinov et al. and Kim et al. [11, 12] , both of whom report that MVP had improved long-term survival compared with MVR. Finally, other authors [9, 10, 13, 14] conclude that MVR provides greater long-term survival than MVP. These conflicting results can be probably explained by heterogeneity in the patients' demographic profiles, the lack of data related to the aetiology of MV disease and the different types of mitral repair used.
Our study confirms that concomitant CABG affects both in-hospital and median survival rates. The in-hospital mortality rate for AV and MV surgery alone was 5.7% compared with 12.5% with CABG (P < 0.001), and the 1-year mortality rate was 11.1 vs 20.3%, respectively (P < 0.01). The negative impact of CABG on the outcome of DVS patients has been documented by other authors [1, 15] . In our study, the comparison of isolated DVS with DVS plus CABG indicates that patients who underwent concomitant CABG were much older, were more likely to have a history of previous myocardial infarction (2.7 vs 19.5%), congestive heart failure (13.7 vs 25%), severely depressed left ventricular ejection fraction (3.7 vs 9.5%), diabetes (12.2 vs 20.5%) and extra-cardiac vasculopathy (8.3 vs 24%). These findings could explain the less satisfactory results obtained in the subgroup of patients who underwent DVS plus CABG.
Differences were seen for both in-hospital mortality and 1-year survival by the type of valve procedure and age of the patient at the time of the procedure. Our results imply that the implantation of both mechanical valves in patients <70 years and tissue valves in both positions in patients ≥70 years can be recommended. Leavitt et al. [15] found that, in patients >70 years of age, the strategies of mechanical valves in both positions or a tissue AV with MVP both had the lowest in-hospital mortality and best long-term survival. Our results confirmed that patients >70 years of age who had implantation of both mechanical valves reported significantly higher in-hospital and 1-year mortality than those <70 years. On the contrary, we found no survival differences in the group of patients <70 or ≥70 years when stratified by surgical procedure type at the 5-year follow-up.
Finally, the multivariable Cox proportional hazards model showed that preoperative and clinical patient-related factors appear to be the major determinant of long-term survival, irrespective of the type of operation. Better clinical status at the time of cardiac surgery probably improves patient outcome in the follow-up.
Our observational registry study has several limitations. Information about the specific type of MVP was not collected, and we were unable to analyse the impact of chordal apparatus preservation on results after MVR. Occurrence of valve-related complications (thromboembolism, endocarditis and anticoagulantrelated haemorrhage) was not analysed in this study. Finally, we had no information about the patients who were not resident in the ER region and excluded from the 1-and 5-year follow-up analysis because of incomplete information on their clinical status after discharge from the hospital.
CONCLUSIONS
This study supplies information that can help in decisions about patients who are potential candidates for DVS.
We found that advanced age, smaller BMI and concomitant CABG are significant high-risk factors for mortality in patients undergoing DVS. Older patients reported worse results with mechanical valves in both positions. MVP allows significantly lower in-hospital mortality, and provides comparable 5-year outcomes with MVR. No significant differences in survival were found in age subgroups when stratified by the surgical procedure at the 5-year follow-up. Multivariable analysis demonstrates that preoperative comorbidities and the clinical status at the time of surgery are the real burden in the successful treatment of patients undergoing mitral-aortic valve procedures.
